The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zurampic



Grünenthal GmbHEU/1/15/1080/001-005

Main Information

Trade NameZurampic
Active SubstancesLesinurad
Dosage FormFilm-coated tablet
Licence HolderGrünenthal GmbH
Licence NumberEU/1/15/1080/001-005

Group Information

ATC CodeM04AB Preparations increasing uric acid excretion

Status

License statusWithdrawn
Withdrawn Date16/07/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back